| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.8M | -28.6% |
| Cost of Revenue | $6.0M | -29.2% |
| Gross Profit | $6.8M | -28.0% |
| R&D Expense | $3.0M | -21.8% |
| SG&A Expense | $10.0M | +13.6% |
| Operating Income | -$13.3M | -27.4% |
| Pre-tax Income | -$11.7M | -3.2% |
| Income Tax | $0 | — |
| Net Income | -$11.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -82.0% |
| Accounts Receivable | $7.3M | +1.0% |
| Inventory | $4.8M | +5.5% |
| Current Assets | $14.0M | -25.4% |
| Total Assets | $20.1M | -24.5% |
| Current Liabilities | $8.6M | +14.6% |
| Total Liabilities | $11.1M | -20.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.8M | -19.9% |
| Capital Expenditures | $188K | +408.1% |
| Investing Cash Flow | -$188K | -408.1% |
| Financing Cash Flow | $6.6M | -14.7% |
| Free Cash Flow | -$12.0M | -21.3% |
| -3.2% |
| EPS (Basic) | -$4.91 | -776.8% |
| EPS (Diluted) | -$4.91 | +41.8% |
| Stockholders' Equity |
| $9.0M |
| -29.0% |